Skip to content

Clinical trials

Lung Diseases, Interstitial trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Country / region: Australia Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20121
20132
20161
20173
20192
20202
20225
20235
20246
20254
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting14
Completed12
Active, not recruiting6
Terminated5
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim6
GlaxoSmithKline3
Insmed Incorporated3
United Therapeutics3
AdAlta Limited2
Bristol-Myers Squibb2
Celgene2
Kyntra Bio2
AllRock Bio, Inc.1
Anne Holland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial39
Idiopathic Pulmonary Fibrosis10
Pulmonary Fibrosis9
Hypertension, Pulmonary6
Connective Tissue Diseases4
Idiopathic Interstitial Pneumonias4
Scleroderma, Diffuse4
Fibrosis3
Lung Diseases3
Scleroderma, Systemic3

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.